Zepbound labeling also directs clinicians to consider treatment response and tolerability when choosing a maintenance dose
At the same time, more serious side effects may involve pancreatitis (inflammation of the pancreas), gallbladder issues, and kidney problems
According to the FDA-approved labels, the most frequently reported adverse reactions include gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, and constipation
Even more astonishingly, when Cagrilintide was paired with Semaglutide in early clinical trials, the results were even more promising showing an extra 7.4% weight loss in addition to taking Semaglutide by itself
Semaglutide begins working right away to suppress appetite and slow gastric emptying, but measurable weight loss usually becomes noticeable after the first 24 weeks